Cargando…
TGFβ1 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells
SIMPLE SUMMARY: Photodynamic therapy (PDT) is used for the treatment of in situ cutaneous squamous cell carcinoma (cSCC), the second most common form of skin cancer, as well as for its precancerous form, actinic keratosis. However, relapses after the treatment can occur. Transforming growth factor β...
Autores principales: | Gallego-Rentero, María, Gutiérrez-Pérez, María, Fernández-Guarino, Montserrat, Mascaraque, Marta, Portillo-Esnaola, Mikel, Gilaberte, Yolanda, Carrasco, Elisa, Juarranz, Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616019/ https://www.ncbi.nlm.nih.gov/pubmed/34830768 http://dx.doi.org/10.3390/cancers13225613 |
Ejemplares similares
-
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy
por: Mascaraque-Checa, Marta, et al.
Publicado: (2022) -
Characterisation of resistance mechanisms developed by basal cell carcinoma cells in response to repeated cycles of Photodynamic Therapy
por: Lucena, Silvia Rocio, et al.
Publicado: (2019) -
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
por: Cerro, Paulina A., et al.
Publicado: (2022) -
Influence of Serum Vitamin D Level in the Response of Actinic Keratosis to Photodynamic Therapy with Methylaminolevulinate
por: Moreno, Ricardo, et al.
Publicado: (2020) -
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy
por: Gracia-Cazaña, Tamara, et al.
Publicado: (2019)